The increase in price target by a reputable analyst like Alex Thompson from Stifel is a strong positive signal for Spyre Therapeutics. It suggests a bullish outlook on the company's future performance and potential growth, likely leading to increased investor confidence and a potential rise in the stock price in the short term.